- Home
- CVAC vs OFIX Comparison
CVAC vs OFIX Comparison
Compare CVAC & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- OFIX
- Stock Information
- Founded
- CVAC 2000
- OFIX 1987
- Country
- CVAC Germany
- OFIX United States
- Employees
- CVAC N/A
- OFIX N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- OFIX Medical/Dental Instruments
- Sector
- CVAC Health Care
- OFIX Health Care
- Exchange
- CVAC Nasdaq
- OFIX Nasdaq
- Market Cap
- CVAC 637.1M
- OFIX 722.6M
- IPO Year
- CVAC 2020
- OFIX N/A
- Fundamental
- Price
- CVAC $2.95
- OFIX $17.93
- Analyst Decision
- CVAC Hold
- OFIX Strong Buy
- Analyst Count
- CVAC 3
- OFIX 3
- Target Price
- CVAC $10.00
- OFIX $23.00
- AVG Volume (30 Days)
- CVAC 523.1K
- OFIX 222.6K
- Earning Date
- CVAC 11-12-2024
- OFIX 11-07-2024
- Dividend Yield
- CVAC N/A
- OFIX N/A
- EPS Growth
- CVAC N/A
- OFIX N/A
- EPS
- CVAC N/A
- OFIX N/A
- Revenue
- CVAC $70,565,734.00
- OFIX $784,249,000.00
- Revenue This Year
- CVAC $738.59
- OFIX $8.83
- Revenue Next Year
- CVAC N/A
- OFIX $6.32
- P/E Ratio
- CVAC N/A
- OFIX N/A
- Revenue Growth
- CVAC 75.11
- OFIX 17.32
- 52 Week Low
- CVAC $2.22
- OFIX $12.08
- 52 Week High
- CVAC $5.28
- OFIX $20.73
- Technical
- Relative Strength Index (RSI)
- CVAC 49.55
- OFIX 44.76
- Support Level
- CVAC $3.17
- OFIX $17.68
- Resistance Level
- CVAC $3.56
- OFIX $18.41
- Average True Range (ATR)
- CVAC 0.18
- OFIX 0.56
- MACD
- CVAC 0.01
- OFIX -0.20
- Stochastic Oscillator
- CVAC 24.69
- OFIX 11.42
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.